s (-26 percent), Cepheid =-21 percent), and GenMark Diagnostics (-21 percent) seeing the steepest de=lines. The biggest gainer during the month was Luminex, whose shares increased 6 percent. The GWDN Index's decline outpaced losses in t=e broader markets. The Dow Jones Industrial Average was down 2 per